Artificial intelligence in abdominal aortic aneurysm.

Journal: Journal of vascular surgery
Published Date:

Abstract

OBJECTIVE: Abdominal aortic aneurysm (AAA) is a life-threatening disease, and the only curative treatment relies on open or endovascular repair. The decision to treat relies on the evaluation of the risk of AAA growth and rupture, which can be difficult to assess in practice. Artificial intelligence (AI) has revealed new insights into the management of cardiovascular diseases, but its application in AAA has so far been poorly described. The aim of this review was to summarize the current knowledge on the potential applications of AI in patients with AAA.

Authors

  • Juliette Raffort
    Clinical Chemistry Laboratory, University Hospital of Nice, Nice, France; Université Côte d'Azur, CHU, Inserm U1065, C3M, Nice, France. Electronic address: juliette.raffort@hotmail.fr.
  • Cédric Adam
    Laboratory of Applied Mathematics and Computer Science (MICS), CentraleSupélec, Université Paris-Saclay, Paris, France.
  • Marion Carrier
    Laboratory of Applied Mathematics and Computer Science (MICS), CentraleSupélec, Université Paris-Saclay, Paris, France.
  • Ali Ballaith
    Department of Vascular Surgery, University Hospital of Nice, Nice, France.
  • Raphael Coscas
    Department of Vascular Surgery, Ambroise Paré University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Boulogne, France; Inserm U1018 Team 5, Versailles-Saint-Quentin et Paris-Saclay Universities, Versailles, France.
  • Elixène Jean-Baptiste
    Université Côte d'Azur, CHU, Inserm U1065, C3M, Nice, France; Department of Vascular Surgery, University Hospital of Nice, Nice, France.
  • Réda Hassen-Khodja
    Université Côte d'Azur, CHU, Inserm U1065, C3M, Nice, France; Department of Vascular Surgery, University Hospital of Nice, Nice, France.
  • Nabil Chakfe
  • Fabien Lareyre
    Université Côte d'Azur, CHU, Inserm U1065, C3M, Nice, France; Department of Vascular Surgery, University Hospital of Nice, Nice, France.